Koca E, Niravath PA, Ensor J, Patel TA, et al. ANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancer. Breast Cancer Res Treat 2021 Apr 15. pii: 10.1007/s10549-021-06214.
PMID: 33860388